{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T16:54:31Z","timestamp":1725468871365},"publisher-location":"Chichester, UK","reference-count":63,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd000203","type":"reference-entry","created":{"date-parts":[[2003,11,21]],"date-time":"2003-11-21T03:14:00Z","timestamp":1069384440000},"source":"Crossref","is-referenced-by-count":17,"title":["Gamma-aminobutyric acid agonists for neuroleptic-induced tardive dyskinesia"],"prefix":"10.1002","author":[{"given":"KVS","family":"Soares","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JJ","family":"McGrath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JJ","family":"Deeks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2001,4,23]]},"reference":[{"issue":"1","key":"10.1002\/14651858.CD000203-BIB1|cit1","first-page":"111","article-title":"Baclofen in the treatment of tardive dyskinesia","volume":"42","author":"Ananth","year":"1987","journal-title":"Current Therapeutic Research"},{"issue":"6","key":"10.1002\/14651858.CD000203-BIB2|cit2","first-page":"289","article-title":"Preliminary observations on the therapeutic action of progabide in tardive dyskinesia","volume":"2","author":"Burner","year":"1989","journal-title":"Brain Dysfunction"},{"key":"10.1002\/14651858.CD000203-BIB3|cit3","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1192\/bjp.150.4.542","article-title":"The effect of sodium valproate on tardive dyskinesia - revisited","volume":"150","author":"Fisk","year":"1987","journal-title":"British Journal of Psychiatry"},{"issue":"7","key":"10.1002\/14651858.CD000203-BIB4|cit4","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1176\/ajp.134.7.781","article-title":"The relationship between parkisonism and tardive dyskinesia","volume":"134","author":"Gerlach","year":"1977","journal-title":"American Journal of Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD000203-BIB5|cit5","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/BF00431840","article-title":"Effect of baclofen on tardive dyskinesia","volume":"56","author":"Gerlach","year":"1978","journal-title":"Psychopharmacology Berlin"},{"key":"10.1002\/14651858.CD000203-BIB6|cit6","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1192\/bjp.129.2.114","article-title":"Effect of sodium valproate on tardive dyskinesia","volume":"129","author":"Linnoila","year":"1976","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000203-BIB7|cit7","first-page":"437","article-title":"Effect of sodium valproate and baclofen in tardive dyskinesia: clinical and neuroendocrine studies","volume":"24","author":"Nair","year":"1980","journal-title":"Advances in Biochemical Psychopharmacology"},{"key":"10.1002\/14651858.CD000203-BIB8|cit8","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1176\/ajp.135.12.1562","article-title":"Baclofen in the treatment of tardive dyskinesia","volume":"135","author":"Nair","year":"1978","journal-title":"American Journal of Psychiatry"},{"issue":"4 II","key":"10.1002\/14651858.CD000203-BIB9|cit9","first-page":"A114","article-title":"Baclofen for tardive dyskinesia: a double-blind placebo-controlled trial","volume":"32","author":"Stewart","year":"1982","journal-title":"Neurology"},{"issue":"4","key":"10.1002\/14651858.CD000203-BIB10|cit10","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1097\/00002826-198212000-00004","article-title":"Baclofen in tardive dyskinesia patients maintained on neuroleptics","volume":"5","author":"Stewart","year":"1982","journal-title":"Clinical Neuropharmacology"},{"issue":"6","key":"10.1002\/14651858.CD000203-BIB11|cit11","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1001\/archpsyc.1987.01800180032006","article-title":"Brain gamma-aminobutyric-acid abnormality in tardive dyskinesia: reduction in cerebrospinal fluid GABA levels and therapeutic response to GABA agonist treatment","volume":"44","author":"Thaker","year":"1987","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD000203-BIB12|cit12","first-page":"483","article-title":"Sodium valproate in tardive dyskinesia","volume":"40","author":"Casey","year":"1979","journal-title":"Journal of Clinical Psychiatry"},{"issue":"12","key":"10.1002\/14651858.CD000203-BIB13|cit13","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1001\/archpsyc.1980.01780250062007","article-title":"Gamma-acetylenic GABA in tardive dyskinesia","volume":"37","author":"Casey","year":"1980","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD000203-BIB14|cit14","first-page":"577","article-title":"Gamma-acetylenic GABA in tardive dyskinesia","volume":"24","author":"Casey","year":"1980","journal-title":"Advances in Biochemical Psychopharmacology"},{"key":"10.1002\/14651858.CD000203-BIB15|cit15","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/0006-3223(92)90035-X","article-title":"GABA agonist induced changes in motor, oculomotor and attention measures correlate in schizophrenics with tardive dyskinesia","volume":"32","author":"Cassady","year":"1992","journal-title":"Biological Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD000203-BIB16|cit16","first-page":"236","article-title":"Pharmacologic relationship of antisaccade and dyskinesia in schizophrenic patients","volume":"29","author":"Cassady","year":"1993","journal-title":"Psychopharmacology Bulletin"},{"issue":"2","key":"10.1002\/14651858.CD000203-BIB17|cit17","first-page":"20","article-title":"Efficacies of agents related to GABA, dopamine, and acetylcholine in the treatment of tardive dyskinesia","volume":"14","author":"Chien","year":"1978","journal-title":"Psychopharmacology Bulletin"},{"issue":"1","key":"10.1002\/14651858.CD000203-BIB18|cit18","first-page":"101","volume":"142","author":"Danion","year":"1984","journal-title":"Annales Medico-Psychologiques Paris"},{"key":"10.1002\/14651858.CD000203-BIB19|cit19","series-title":"Progress in Neuropsychopharmacology","article-title":"Lioresal in the treatment of neuroleptic-induced tardive dyskinesia","author":"Frangos","year":"1980"},{"issue":"3","key":"10.1002\/14651858.CD000203-BIB20|cit20","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/j.1600-0447.1983.tb00339.x","article-title":"Sodium valproate and biperiden in neuroleptic-induced akathisia, parkinsonism and hyperkinesia: a double-blind crossover study with placebo","volume":"67","author":"Friis","year":"1983","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1002\/14651858.CD000203-BIB21|cit21","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1192\/bjp.133.1.82","article-title":"Sodium valproate and tardive dyskinesia","volume":"133","author":"Gibson","year":"1978","journal-title":"British Journal of Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD000203-BIB22|cit22","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1007\/BF00432517","article-title":"The treatment of tardive dyskinesia with baclofen","volume":"87","author":"Glazer","year":"1985","journal-title":"Psychopharmacology"},{"issue":"1","key":"10.1002\/14651858.CD000203-BIB23|cit23","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1600-0447.1976.tb00090.x","article-title":"Baclofen (Lioresal) in the treatment of neuroleptic-induced tardive dyskinesia","volume":"54","author":"Korsgaard","year":"1976","journal-title":"Acta Psychiatrica Scandinavica"},{"issue":"9","key":"10.1002\/14651858.CD000203-BIB24|cit24","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1001\/archpsyc.1982.04290090021005","article-title":"The effect of tetrahydroisooxazolopyridinol (THIP) in tardive dyskinesia: a new gamma-aminobutyric-acid agonist","volume":"39","author":"Korsgaard","year":"1982","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD000203-BIB25|cit25","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0165-1781(83)90014-8","article-title":"Effect of gamma-vinyl-GABA in tardive dyskinesia","volume":"8","author":"Korsgaard","year":"1983","journal-title":"Psychiatry Research"},{"issue":"3","key":"10.1002\/14651858.CD000203-BIB26|cit26","first-page":"371","volume":"8","author":"Lambert","year":"1982","journal-title":"L'Encephale"},{"key":"10.1002\/14651858.CD000203-BIB27|cit27","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/BF00177564","article-title":"Prolactin response to sodium valproate in shizophrenics with and without tardive dyskinesia","volume":"96","author":"Monteleone","year":"1988","journal-title":"Psychopharmacology"},{"issue":"Suppl","key":"10.1002\/14651858.CD000203-BIB28|cit28","first-page":"128","article-title":"Clinical activity of GABA agonists in neuroleptic and L-dopa-induced dyskinesia","volume":"2","author":"Morselli","year":"1985","journal-title":"Psychopharmacology"},{"issue":"3","key":"10.1002\/14651858.CD000203-BIB29|cit29","first-page":"509","article-title":"Cerebrospinal fluid monoamine metabolites and cyclic nucleotides in schizophrenic patients with tardive dyskinesia or drug-induced tremor","volume":"14","author":"Nagao","year":"1979","journal-title":"Biological Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD000203-BIB30|cit30","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0006-3223(85)90084-8","article-title":"A placebo-controlled trial of valproate in tardive dyskinesia","volume":"20","author":"Nasrallah","year":"1985","journal-title":"Biological Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD000203-BIB31|cit31","first-page":"56","article-title":"Pharmacologic probes of neurotransmitter systems in tardive dyskinesia: implications for clinical management","volume":"47","author":"Nasrallah","year":"1986","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD000203-BIB32|cit32","series-title":"Abstracts of 13th Collegium Internationale Neuropsychopharmacologicum Congress","article-title":"The effect of progabide, a specific GABAergic agonist, on neuroleptic-induced tardive dyskinesia - a result of a pilot study","author":"Bathien","year":"1982"},{"key":"10.1002\/14651858.CD000203-BIB33|cit33","first-page":"361","article-title":"Movement disorders in patients with coexistent neuroleptic-induced tremor and tardive dyskinesia: EMG and pharmacological study","volume":"45","author":"Rondot","year":"1987","journal-title":"Advances in Neurology"},{"issue":"2","key":"10.1002\/14651858.CD000203-BIB34|cit34","first-page":"16","article-title":"Baclofen in the treatment of tardive dyskinesia and schizophrenia","volume":"14","author":"Simpson","year":"1978","journal-title":"Psychopharmacology Bulletin"},{"issue":"8","key":"10.1002\/14651858.CD000203-BIB35|cit35","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/0006-3223(85)90214-8","article-title":"Gamma-vinyl-GABA treatment of tardive dyskinesia and other movement disorders","volume":"20","author":"Stahl","year":"1985","journal-title":"Biological Psychiatry"},{"key":"10.1002\/14651858.CD000203-BIB36|cit36","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1001\/archpsyc.1979.01780050105013","article-title":"Improvement in tardive dyskinesia after muscimol therapy","volume":"36","author":"Tamminga","year":"1979","journal-title":"Archives of General Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD000203-BIB37|cit37","doi-asserted-by":"crossref","first-page":"302","DOI":"10.3928\/0048-5713-19890601-08","article-title":"Gamma-aminobutyric-acid (GABA) pathways in tardive dyskinesia","volume":"19","author":"Nguyen","year":"1989","journal-title":"Psychiatric Annals"},{"key":"10.1002\/14651858.CD000203-BIB38|cit38","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0140-6736(83)90075-2","article-title":"GABA agonist treatment improves tardive dyskinesia","volume":"2","author":"Tamminga","year":"1983","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD000203-BIB39|cit39","article-title":"Tardive dyskinesia: GABA agonist treatment","volume-title":"Catecholamines: neuropharmacology and central nervous system - therapeutic aspects","author":"Tamminga","year":"1994"},{"key":"10.1002\/14651858.CD000203-BIB40|cit40","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1159\/000408491","article-title":"GABA system: clinical research and treatment of tardive dyskinesia","volume":"21","author":"Thaker","year":"1983","journal-title":"Modern Problems in Pharmacopsychiatry"},{"issue":"10","key":"10.1002\/14651858.CD000203-BIB41|cit41","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1056\/NEJM198109033051015","article-title":"Effects of gamma-vinyl GABA","volume":"305","author":"Tell","year":"1981","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD000203-BIB42|cit42","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1136\/bmj.313.7066.1200","volume":"313","author":"Altman","year":"1996","journal-title":"BMJ"},{"volume-title":"Tardive dyskinesia: a task force report of the American Psychiatric Association","year":"1992","key":"10.1002\/14651858.CD000203-BIB43|cit43"},{"key":"10.1002\/14651858.CD000203-BIB44|cit44","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1136\/jnnp.46.6.540","article-title":"A comparison of purposeless movements in psychiatric patients treated with antipsychotic drugs, and normal individuals","volume":"46","author":"Barnes","year":"1983","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"key":"10.1002\/14651858.CD000203-BIB45|cit45","article-title":"Tardive dyskinesia: risk factors, pathophysiology and treatment","volume-title":"Recent Advances in Clinical Psychiatry","volume":"6","author":"Barnes","year":"1988"},{"key":"10.1002\/14651858.CD000203-BIB46|cit46","doi-asserted-by":"crossref","DOI":"10.1016\/B978-0-12-079035-7.50021-X","article-title":"The side-effects of antipsychotic drugs. I. CNS and neuromuscular effects","volume-title":"Antipsychotic drugs and their side-effects","author":"Barnes","year":"1993"},{"key":"10.1002\/14651858.CD000203-BIB47|cit47","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1192\/bjp.144.5.498","article-title":"Tardive dyskinesia: fluctuating patient or fluctuating rater","volume":"144","author":"Bergen","year":"1984","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000203-BIB48|cit48","article-title":"Tardive dyskinesia: pathophysiology","volume-title":"Psychopharmacology. The Fourth Generation of Progress","author":"Casey","year":"1994"},{"key":"10.1002\/14651858.CD000203-BIB49|cit49","article-title":"Cochrane Reviewers Handbook 4.1 [updated June 2000]","author":"Clarke","year":"2000","journal-title":"Review Manager (RevMan) [Computer program]. Version 4.1"},{"issue":"7109","key":"10.1002\/14651858.CD000203-BIB50|cit50","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD000203-BIB51|cit51","article-title":"The treatment of tardive dyskinesia","volume-title":"Psychopharmacology. The Fourth Generation of Progress","author":"Gardos","year":"1994"},{"issue":"1","key":"10.1002\/14651858.CD000203-BIB52|cit52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000468206","article-title":"The movement pattern of oral tardive dyskinesia in relation to anticholinergic and antidopaminergic treatment","volume":"11","author":"Gerlach","year":"1976","journal-title":"International Pharmacopsychiatry"},{"key":"10.1002\/14651858.CD000203-BIB53|cit53","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/309347a0","article-title":"Association with persistent neuroleptic induced dyskinesia of regional changes in brain GABA synthesis","volume":"309","author":"Gunne","year":"1984","journal-title":"Nature"},{"volume-title":"ECDEU assessment manual for psychopharmacology. National Institute of Mental Health Publication No. 76-338","year":"1976","author":"Guy","key":"10.1002\/14651858.CD000203-BIB54|cit54"},{"key":"10.1002\/14651858.CD000203-BIB55|cit55","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/1097-4679(196501)21:1<65::AID-JCLP2270210122>3.0.CO;2-I","article-title":"The nurses' observation scale for inpatient evaluation. A new scale for measuring improvement in chronic schizophrenia","volume":"21","author":"Honigfeld","year":"1965","journal-title":"Journal of Clinical Psychology"},{"volume-title":"Understanding and treating tardive dyskinesia","year":"1982","author":"Jeste","key":"10.1002\/14651858.CD000203-BIB56|cit56"},{"issue":"4 Suppl","key":"10.1002\/14651858.CD000203-BIB57|cit57","first-page":"38S","article-title":"Pharmacological treatments of tardive dyskinesia in the 1980s","volume":"8","author":"Jeste","year":"1988","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"4","key":"10.1002\/14651858.CD000203-BIB58|cit58","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1600-0447.1977.tb00174.x","article-title":"A standardized psychiatric assessment scale for rating chronic psychotic patients","volume":"55","author":"Krawiecka","year":"1977","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1002\/14651858.CD000203-BIB59|cit59","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1192\/bjp.176.3.249","article-title":"Unpublished rating scales: a major source of bias in randomised controlled trials of treatments for schizophrenia","volume":"176","author":"Marshall","year":"2000","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000203-BIB60|cit60","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2466\/pr0.1962.10.3.799","article-title":"The Brief Psychiatric Rating Scale","volume":"10","author":"Overall","year":"1962","journal-title":"Psychological Reports"},{"issue":"4","key":"10.1002\/14651858.CD000203-BIB61|cit61","first-page":"431","article-title":"The clinical research base for the treatment of schizophrenia","volume":"29","author":"Schooler","year":"1993","journal-title":"Psychopharmacology Bulletin"},{"key":"10.1002\/14651858.CD000203-BIB62|cit62","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/jama.1995.03520290060030","article-title":"Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials","volume":"273","author":"Schulz","year":"1995","journal-title":"JAMA"},{"issue":"2","key":"10.1002\/14651858.CD000203-BIB63|cit63","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/BF00496058","article-title":"A rating scale for tardive dyskinesia","volume":"64","author":"Simpson","year":"1979","journal-title":"Psychopharmacology (Berlin)"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD000203","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T20:55:19Z","timestamp":1628542519000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD000203"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,4,23]]},"references-count":63,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd000203","relation":{},"subject":[],"published":{"date-parts":[[2001,4,23]]}}}